22 results on '"Planting, A.S.T."'
Search Results
2. Phase I and pharmacological study of increased dose oral topotecan in combination with intravenous cisplatin
3. Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancer
4. Docetaxel and cisplatin: An active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck: Results of a phase II study of the EORTC Early Clinical Studies Group
5. Docetaxel and ifosfamide in patients with advanced solid tumors: results of a phase I study
6. Oral ZD9331, a non-polyglutamated thymidylate synthase (TS) inhibitor: a phase I and pharmacologic study
7. Five days of oral topotecan (hycamtin ®), a phase I and pharmacological study in adult patients with solid tumours
8. Comparison of two carboplatin-containing regimens with standard chemotherapy for small cell Lung Cancer in a randomised phase II study
9. Etoposide in malignant pleural mesothelioma: Two phase II trials of the EORTC lung cancer cooperative group
10. Phase II study of weekly high-dose cisplatin for six cycles in patients with locally advanced squamous cell carcinoma of the head and neck
11. Neurotoxicity is not enhanced by increased dose intensities of cisplatin administration
12. Phase I study of intravenous fosquidone (GR63178A-NSC D611615) using a three times a week schedule
13. Efficacy and side effects of two chemotherapy regimens with cisplatin plus fluorouracil in advanced squamous cell carcinoma of the head and neck
14. Phase II study of a closely spaced ifosfamide—cisplatin schedule with the addition of G-CSF in advanced non-small-cell lung cancer and malignant melanoma
15. Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in pleural mesothelioma
16. Phase I study of weekly high-dose cisplatin combined with long-term oral etoposide in advanced solid tumors
17. Phase II study of daily oral miltefosine (hexadecylphosphocholine) in advanced colorectal cancer
18. Weekly high-dose cisplatin in malignant pleural mesothelioma
19. Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in metastatic malignant melanoma
20. 392 Randomized Phase II study of weekly cisplatin with or without amifostine in patients with advanced head and neck cancer
21. This letter was referred to the author, who responds as follows
22. 48 Phase II trials of etoposide in malignant pleural mesothelioma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.